Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Activation Product, Factor IX, Serum Thrombotic Accelerator Activity, and Serum-induced Thrombosis
Daniel Deykin, Stanford Wessler
Daniel Deykin, Stanford Wessler
Published February 1, 1964
Citation Information: J Clin Invest. 1964;43(2):160-166. https://doi.org/10.1172/JCI104900.
View: Text | PDF
Research Article

Activation Product, Factor IX, Serum Thrombotic Accelerator Activity, and Serum-induced Thrombosis

  • Text
  • PDF
Abstract

Authors

Daniel Deykin, Stanford Wessler

×

Total citations by year

Year: 2023 2016 1987 1981 1970 1966 1965 1962 Total
Citations: 1 1 1 1 1 1 1 1 8
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (8)

Title and authors Publication Year
Thrombosis Models: An Overview of Common In Vivo and In Vitro Models of Thrombosis
Ayyoub S, Orriols R, Oliver E, Ceide OT
International journal of molecular sciences 2023
Mouse Models of Vascular Diseases
M Sata
2016
Current views on the pathophysiology and investigations of thrombotic disorders
HH Salem, CA Mitchell, BG Firkin
American Journal of Hematology 1987
The Role of Haemostatic Mechanisms
OD Ratnoff
Clinics in Haematology 1981
Local and systemic factors in the pathogenesis of thrombosis
D Deykin
California medicine 1970
The role of the liver in serum-induced hypercoagulability
D Deykin
Journal of Clinical Investigation 1966
Effects of enovid on blood clotting factors
J Donayre, G Pincus
Metabolism 1965
Verhandlungen der Deutschen Gesellschaft für Innere Medizin
B Schlegel
1962

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts